HEARTio
Develops an artificial intelligence platform designed to analyze electrocardiograms (ECG) for the early detection and prediction of heart attacks to improve cardiovascular outcomes.
Overview
HEARTio is a medical technology startup focused on leveraging artificial intelligence to enhance cardiac diagnostics. The company builds a platform that utilizes machine learning algorithms to analyze ECG data, specifically aiming to predict the occurrence of heart attacks before they happen. This technology serves the healthcare sector, targeting hospitals and clinicians who require more accurate and rapid diagnostic tools for cardiovascular health. The company's primary differentiator lies in its focus on predictive capabilities within standard electrocardiograms, potentially reducing emergency response times and improving patient survival rates. HEARTio recently secured $4 million in a Seed funding round in March 2026. This capital is intended to validate their technology and expand clinical proof-of-concept studies to demonstrate the efficacy of AI-driven ECG analysis.
Funding History
Can ECG predict heart attacks? HEARTio raises $4.25M to prove it. Here’s how!
Frequently Asked Questions
- How much has HEARTio raised in total?
- HEARTio has raised a total of $4M across 1 funding round.
- Who are HEARTio's investors?
- HEARTio's investors include Undisclosed.
- What does HEARTio do?
- HEARTio is a medical technology startup focused on leveraging artificial intelligence to enhance cardiac diagnostics. The company builds a platform that utilizes machine learning algorithms to analyze ECG data, specifically aiming to predict the occurrence of heart attacks before they happen. This technology serves the healthcare sector, targeting hospitals and clinicians who require more accurate and rapid diagnostic tools for cardiovascular health. The company's primary differentiator lies in its focus on predictive capabilities within standard electrocardiograms, potentially reducing emergency response times and improving patient survival rates. HEARTio recently secured $4 million in a Seed funding round in March 2026. This capital is intended to validate their technology and expand clinical proof-of-concept studies to demonstrate the efficacy of AI-driven ECG analysis.
- Where is HEARTio headquartered?
- HEARTio is headquartered in San Francisco, CA.
Investors
Related Insights
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
The AI Healthcare sector is one of the most dynamic areas of AI investment in 2026. This report profiles the top-funded startups in the space, their investors, and the market dynamics driving growth.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.